LexDanaLexDanabeta
Inventor

Spencer E. BRIGHTMAN

Inventor
US

Overview

3→
Patents
2023–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
Y02ATechnologies for adaptation to climate change21%
C07DHeterocyclic compounds14%
C12NMicroorganisms or enzymes14%
Y02PClimate change mitigation technologies in the production or processing of goods7%
PatentTitleYear
12,268,739Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune response202511,730,810Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response202311,673,891Imidazopyrimidine compounds and uses thereof2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2025Patents assigned to CHILDRENS MEDICAL CENTER (3)· patent assignee history
2023–2025Patents assigned to DANA FARBER CANCER INST INC (3)· patent assignee history
2023–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CHILDRENS MEDICAL CENTER32023–2025
DANA FARBER CANCER INST INC32023–2025
Locations
LocationPatentsSpan
US32023–2025